Arcadia Biosciences (RKDA) Retained Earnings (2016 - 2025)
Arcadia Biosciences (RKDA) has disclosed Retained Earnings for 11 consecutive years, with -$279.9 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Retained Earnings fell 239314.53% year-over-year to -$279.9 million, compared with a TTM value of -$279.9 million through Sep 2025, down 239314.53%, and an annual FY2024 reading of -$278.9 million, down 2.59% over the prior year.
- Retained Earnings was -$279.9 million for Q3 2025 at Arcadia Biosciences, roughly flat from -$280.7 million in the prior quarter.
- Across five years, Retained Earnings topped out at $117000.0 in Q3 2024 and bottomed at -$280.7 million in Q2 2025.
- Average Retained Earnings over 5 years is -$214.7 million, with a median of -$253.6 million recorded in 2022.
- The sharpest move saw Retained Earnings surged 100.03% in 2023, then crashed 1301061.9% in 2024.
- Year by year, Retained Earnings stood at -$226.5 million in 2021, then fell by 13.85% to -$257.9 million in 2022, then decreased by 5.42% to -$271.8 million in 2023, then decreased by 2.59% to -$278.9 million in 2024, then fell by 0.36% to -$279.9 million in 2025.
- Business Quant data shows Retained Earnings for RKDA at -$279.9 million in Q3 2025, -$280.7 million in Q2 2025, and -$276.3 million in Q1 2025.